% Expired Patents = 57.1

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 33

Loading Chart...

4 inventors (with patents filed for the assignee):

Flemming Larsen (5 out of 5 patents)

Ulla Wahlers (5 out of 5 patents)

Steffen Thiel (2 out of 13 patents)

4. Jens Chr Jensenius (2 out of 5 patents)

5. Jens Christian Jensenius (8 patents)

7 patents: Sort by Forward Citations

1. 11225526 - Antibodies to MASP-2 (2022-01-18),

2. 11008405 - Antibodies to MASP-2 (2021-05-18),

3. 11008404 - Antibodies to MASP-2 (2021-05-18),

4. 10189909 - Antibodies to MASP-2 (2019-01-29),

5. 9441262 - MASP-2, a complement fixing enzyme, and uses for it (2016-09-13),

6. 9096676 - Antibodies to MASP-2 (2015-08-04),

7. 8551790 - MASP 2, a complement-fixing enzyme, and uses for it (2013-10-08),

Helion Biotech Aps is a leading biotechnology company specializing in developing innovative therapies for cancer treatment. With a team of experienced scientists and cutting-edge technology, Helion Biotech is dedicated to pushing the boundaries of medical science and improving the lives of patients worldwide. Their focus on precision medicine and personalized treatment options sets them apart in the competitive biotech industry.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#44 in Copenhagen

#365 in Denmark

Copenhagen, Denmark

Helion Biotech Aps

Forward Citations = 33

4 inventors:

Flemming Larsen (5 out of 5 patents)

Ulla Wahlers (5 out of 5 patents)

Steffen Thiel (2 out of 13 patents)

4. Jens Chr Jensenius (2 out of 5 patents)

5. Jens Christian Jensenius (8 patents)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]